Avanos Medical (AVNS) News Today $14.32 +0.16 (+1.11%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$14.34 +0.02 (+0.15%) As of 03/27/2025 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Avanos Medical (NYSE:AVNS) Sets New 12-Month Low - Here's WhyAvanos Medical (NYSE:AVNS) Reaches New 12-Month Low - Here's WhyMarch 26 at 5:12 PM | marketbeat.comAvanos Medical Q3 EPS Estimate Decreased by Zacks ResearchMarch 25 at 2:05 AM | americanbankingnews.comIntech Investment Management LLC Purchases 40,186 Shares of Avanos Medical, Inc. (NYSE:AVNS)Intech Investment Management LLC raised its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 467.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 48,782 shares of the company's stock after acquiring an additional 40,186 sharMarch 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $7.32 Million Stock Position in Avanos Medical, Inc. (NYSE:AVNS)Charles Schwab Investment Management Inc. lowered its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 12.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 460,016 shares of the company's stock after selling 63,478 shares duringMarch 24, 2025 | marketbeat.comZacks Research Lowers Earnings Estimates for Avanos MedicalAvanos Medical, Inc. (NYSE:AVNS - Free Report) - Zacks Research reduced their Q3 2025 earnings estimates for shares of Avanos Medical in a research report issued to clients and investors on Wednesday, March 19th. Zacks Research analyst R. Department now forecasts that the company will post earninMarch 24, 2025 | marketbeat.comAvanos Medical Q1 EPS Estimate Lowered by Zacks ResearchAvanos Medical, Inc. (NYSE:AVNS - Free Report) - Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for shares of Avanos Medical in a research report issued on Wednesday, March 19th. Zacks Research analyst R. Department now expects that the compaMarch 22, 2025 | marketbeat.comQ1 EPS Estimates for Avanos Medical Reduced by AnalystMarch 22, 2025 | americanbankingnews.comWilliam Blair Investment Management LLC Raises Position in Avanos Medical, Inc. (NYSE:AVNS)William Blair Investment Management LLC boosted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,406,210 shares of the company's stoMarch 19, 2025 | marketbeat.comStockNews.com Upgrades Avanos Medical (NYSE:AVNS) to "Buy"March 19, 2025 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Rating Increased to Buy at StockNews.comStockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday.March 19, 2025 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Sees Significant Growth in Short InterestAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 888,700 shares, an increase of 25.7% from the February 13th total of 707,000 shares. Based on an average daily volume of 492,300 shares, the short-interest ratio is presently 1.8 days. Currently, 2.0% of the company's stock are sold short.March 18, 2025 | marketbeat.comBank of New York Mellon Corp Sells 21,550 Shares of Avanos Medical, Inc. (NYSE:AVNS)Bank of New York Mellon Corp cut its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 6.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 316,239 shares of the companMarch 18, 2025 | marketbeat.comAvanos Medical Names David Pacitti as Next CEOMarch 17, 2025 | marketwatch.comAvanos names David Pacitti as CEO, effective April 14March 17, 2025 | markets.businessinsider.comAvanos Medical Announces Appointment of David Pacitti as Chief Executive OfficerMarch 17, 2025 | prnewswire.comAvanos Medical (NYSE:AVNS) Hits New 1-Year Low - Here's WhyAvanos Medical (NYSE:AVNS) Sets New 52-Week Low - Here's WhyMarch 13, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Downgraded to Hold Rating by StockNews.comStockNews.com cut Avanos Medical from a "buy" rating to a "hold" rating in a research report on Tuesday.March 12, 2025 | marketbeat.comDo Options Traders Know Something About Avanos (AVNS) Stock We Don't?March 11, 2025 | msn.comInsider Selling: Avanos Medical, Inc. (NYSE:AVNS) SVP Sells 7,000 Shares of StockAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the transaction, the senior vice president now owns 82,047 shares in the company, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 11, 2025 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) SVP Sells $106,750.00 in StockMarch 11, 2025 | insidertrades.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | insidermonkey.comAvanos Medical’s Earnings Call: Mixed Sentiments and 2025 OutlookFebruary 27, 2025 | tipranks.comAvanos Medical (NYSE:AVNS) Releases Earnings Results, Beats Expectations By $0.03 EPSAvanos Medical (NYSE:AVNS - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%.February 27, 2025 | marketbeat.comAvanos Medical Inc (AVNS) Q4 2024 Earnings Call Highlights: Strong Organic Growth Amidst ...February 27, 2025 | finance.yahoo.comAvanos price target lowered to $17 from $20 at StifelFebruary 27, 2025 | markets.businessinsider.comAvanos sees FY25 EPS $1.05-$1.25, consensus $1.67February 27, 2025 | markets.businessinsider.comAvanos Medical Inc. (AVNS) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comAvanos Medical (NYSE:AVNS) Reaches New 1-Year Low - What's Next?Avanos Medical (NYSE:AVNS) Sets New 52-Week Low - Here's WhyFebruary 26, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Issues FY 2025 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its FY 2025 earnings guidance. The company provided EPS guidance of 1.050-1.250 for the period, compared to the consensus estimate of 1.670. The company also issued revenue guidance of $665.0 millionillion-$685.0 millionillion, compared to the consensus estimate of $713.1 millionillion.February 26, 2025 | marketbeat.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 ResultsFebruary 26, 2025 | prnewswire.comAvanos Medical (AVNS) to Release Earnings on WednesdayAvanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Shares Down 6.3% - Here's What HappenedAvanos Medical (NYSE:AVNS) Stock Price Down 6.3% - Here's What HappenedFebruary 19, 2025 | marketbeat.comAvanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial ResultsFebruary 19, 2025 | prnewswire.comRice Hall James & Associates LLC Makes New $989,000 Investment in Avanos Medical, Inc. (NYSE:AVNS)Rice Hall James & Associates LLC bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 62,129 shares of the company's stock, vFebruary 19, 2025 | marketbeat.comParadice Investment Management LLC Buys 30,949 Shares of Avanos Medical, Inc. (NYSE:AVNS)Paradice Investment Management LLC lifted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,293,198 shares of the company's stock after purchasing an addFebruary 18, 2025 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Sees Large Decline in Short InterestAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 632,000 shares, a drop of 5.2% from the January 15th total of 666,900 shares. Currently, 1.4% of the company's stock are sold short. Based on an average daily trading volume, of 444,200 shares, the days-to-cover ratio is currently 1.4 days.February 18, 2025 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Position Increased by Empowered Funds LLCEmpowered Funds LLC increased its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 141.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 153,834 shares of the company's stock after purchasing an additional 90,091 shares during the period. EmFebruary 15, 2025 | marketbeat.comAvanos Medical (AVNS) Expected to Announce Earnings on TuesdayAvanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Tuesday, February 18, Financial Modeling Prep reports.February 11, 2025 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Short Interest UpdateAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 681,400 shares, a decline of 6.4% from the December 31st total of 727,700 shares. Based on an average trading volume of 349,300 shares, the days-to-cover ratio is currently 2.0 days. Currently, 1.5% of the shares of the company are short sold.February 1, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Stock Price Up 6.5% - Should You Buy?Avanos Medical (NYSE:AVNS) Shares Up 6.5% - Should You Buy?January 27, 2025 | marketbeat.comAvanos (AVNS) Declined due to Reduced Earnings GuidanceJanuary 27, 2025 | msn.comWhy Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth WatchingJanuary 26, 2025 | uk.finance.yahoo.comTributary Capital Management LLC Purchases 246,379 Shares of Avanos Medical, Inc. (NYSE:AVNS)Tributary Capital Management LLC raised its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 38.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 893,008 shares of the company's stock after purchasing anJanuary 25, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Issues Q4 2024 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its fourth quarter 2024 earnings guidance. The company provided EPS guidance of 0.380-0.430 for the period, compared to the consensus estimate of 0.400. The company also issued revenue guidance of $175.0 millionillion-$180.0 millionillion, compared to the consensus estimate of $177.2 millionillion.January 13, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Updates Q4 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.38-0.43 for the period, compared to the consensus estimate of $0.40. The company also issued revenue guidance of $175-180 millionillion, compared to the consensus estimate of $177.25 millionillion.January 13, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Hits New 12-Month Low - Here's What HappenedAvanos Medical (NYSE:AVNS) Reaches New 52-Week Low - Here's WhyJanuary 13, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Sees Large Volume Increase - Here's What HappenedAvanos Medical (NYSE:AVNS) Sees Unusually-High Trading Volume - Still a Buy?January 10, 2025 | marketbeat.comAvanos Medical (NYSE:AVNS) Sets New 52-Week Low - What's Next?Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low - Time to Sell?January 6, 2025 | marketbeat.comAvanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | prnewswire.comAvanos Medical FY2026 EPS Estimate Lowered by Zacks ResearchAvanos Medical, Inc. (NYSE:AVNS - Free Report) - Equities research analysts at Zacks Research reduced their FY2026 earnings per share estimates for Avanos Medical in a report issued on Tuesday, December 31st. Zacks Research analyst R. Department now anticipates that the company will post earningsJanuary 3, 2025 | marketbeat.com Remove Ads Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Media Mentions By Week AVNS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVNS News Sentiment▼-0.160.78▲Average Medical News Sentiment AVNS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVNS Articles This Week▼133▲AVNS Articles Average Week Remove Ads Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TransMedics Group News Today Soleno Therapeutics News Today Enovis News Today LivaNova News Today NovoCure News Today Warby Parker News Today LeMaitre Vascular News Today CONMED News Today Tandem Diabetes Care News Today Liquidia News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AVNS) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVNS Stock Free AVNS Stock Alerts